Neoleukin Therapeutics In... (NLTX)

AI Score

Unlock

3.49

0.05 (1.45%)

At close: Dec 18, 2023, 9:00 PM

Neoleukin Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	25.23M	31.11M	35.49M	37.89M	40.34M	77.53M	128.06M	142.47M	154.92M	164.24M	178.39M	192.56M	201.15M	129.6M	139.42M	143.09M	66.31M	72.7M	74.17M	76.93M	86.73M	99.13M	66.61M	52.03M	47.1M	27.15M	20.92M	32.3M	86.22M	22.47M	35.69M
Short-Term Investments	53.28M	50.95M	47.94M	58.5M	66.54M	38.93M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.01M	26.05M	56.05M	72.59M	104.13M	100.67M	70.76M	59.71M	44.09M	33.02M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	20.01M	50.05M	16.67M	32.66M	38.62M
Other Long-Term Assets	524K	529K	905K	936K	1.91M	2.02M	1.95M	1.93M	1.99M	1.93M	1.92M	1.93M	997K	1.13M	535K	30K	29K	30K	33K	53K	54K	404K	551K	599K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	236K	503K	1.28M	509K	662K	237K	562K	1.1M	1.56M	740K	878K	915K	855K	426K	676K	1.09M	772K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.39M	1.72M	2.2M	2.75M	1.98M	2.03M	2.31M	1.52M	1.57M	3.26M	2.92M	1.97M	5.44M	1.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	79.89M	83.78M	85.64M	99.13M	108.86M	118.48M	130.37M	143.99M	156.5M	167.5M	181.31M	194.52M	206.59M	131M	139.65M	143.6M	67.58M	73.21M	74.83M	77.17M	87.29M	103.24M	94.22M	108.83M	120.57M	132.19M	122.44M	103.48M	146.61M	67.65M	69.49M
Property-Plant & Equipment	9.17M	9.7M	11.92M	15.88M	15.81M	16.5M	16.74M	17.22M	17.27M	17.36M	16.58M	13.72M	13.7M	12.74M	12.35M	2.83M	1.56M	504K	570K	400K	467K	781K	849K	905K	1.03M	1.09M	885K	849K	791K	387K	104K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	18K	73K	128K	183K	238K	293K	347K	403K	458K	513K	567K	622K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	9.69M	10.22M	12.82M	16.81M	17.72M	18.54M	18.76M	19.27M	19.44M	19.53M	18.8M	16M	15.1M	14.33M	13.4M	3.43M	2.21M	534K	603K	453K	521K	1.19M	1.4M	1.5M	1.03M	1.09M	20.89M	50.9M	17.46M	33.05M	38.73M
Total Assets	89.59M	94M	98.46M	115.95M	126.58M	137.02M	149.13M	163.26M	175.93M	187.02M	200.1M	210.52M	221.69M	145.32M	153.05M	147.02M	69.79M	73.74M	75.43M	77.62M	87.81M	104.43M	95.62M	110.33M	121.6M	133.28M	143.33M	154.38M	164.07M	100.7M	108.21M
Account Payables	n/a	n/a	n/a	478K	8.86M	7.89M	6.33M	526K	7.77M	6.41M	7.31M	1.32M	9.52M	6.01M	5M	1.6M	2.3M	958K	3.4M	702K	10.75M	13.35M	9.36M	6.02M	7M	8.13M	5.82M	6.86M	8.56M	8.5M	5.72M
Deferred Revenue	n/a	n/a	n/a	n/a	-8.86M	-7.89M	-6.33M	n/a	-7.77M	-6.41M	-7.31M	-696.69K	-9.52M	-6.01M	-5M	n/a	-2.3M	-958K	-3.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.55M	1.49M	1.74M	1.51M	1.38M	1.39M	1.27M	1.22M	1.22M	1.18M	1.1M	708K	370K	306K	600K	618K	265K	201K	200K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	3.66M	3.39M	5.42M	9.07M	8.86M	7.89M	6.33M	6.89M	7.77M	6.41M	7.31M	6.55M	9.52M	6.01M	5M	2.52M	2.3M	958K	3.4M	3.92M	n/a	n/a	n/a	4.94M	n/a	n/a	n/a	2.66M	n/a	n/a	n/a
Total Current Liabilities	5.21M	4.88M	7.16M	11.06M	10.24M	9.27M	7.6M	8.64M	9M	7.58M	8.41M	7.89M	9.89M	6.32M	5.6M	4.74M	2.56M	1.16M	3.6M	4.63M	10.75M	13.35M	9.36M	10.96M	7M	8.13M	5.82M	9.52M	8.56M	8.5M	5.72M
Long-Term Debt	9.14M	9.55M	9.95M	10.55M	10.69M	11.04M	11.44M	11.76M	12.07M	12.37M	12.73M	11.41M	11.46M	10.3M	10.33M	593K	351K	255K	296K	6K	10K	24K	28K	33K	37K	40K	44K	47K	26K	7K	7K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	313K	333K	377K	415K	453K	476K	508K	518K	150K	116K	107K	99K
Total Long-Term Liabilities	9.14M	9.55M	9.95M	10.55M	10.69M	11.04M	11.44M	11.76M	12.07M	12.37M	12.73M	11.41M	11.46M	10.3M	10.33M	593K	351K	255K	296K	319K	343K	401K	443K	486K	513K	548K	562K	197K	142K	114K	106K
Total Liabilities	14.35M	14.43M	17.1M	21.62M	20.93M	20.31M	19.03M	20.4M	21.07M	19.95M	21.14M	19.3M	21.35M	16.63M	15.93M	5.34M	2.92M	1.41M	3.89M	4.95M	11.09M	13.75M	9.8M	11.44M	7.51M	8.68M	6.39M	9.72M	8.71M	8.61M	5.83M
Total Debt	10.69M	11.04M	11.68M	12.07M	12.07M	12.43M	12.71M	12.98M	13.29M	13.54M	13.83M	12.12M	11.83M	10.61M	10.93M	1.21M	616K	456K	496K	6K	10K	24K	28K	33K	37K	40K	44K	47K	26K	7K	7K
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-37M	n/a	n/a	n/a	-37M	n/a	n/a	n/a
Retained Earnings	-471.87M	-467.34M	-465.26M	-451.06M	-437.61M	-424.54M	-408.85M	-393.5M	-378.33M	-362.88M	-347.76M	-332.81M	-320.17M	-317.92M	-308.17M	-299.53M	-291.43M	-232.3M	-232.29M	-230.09M	-225.2M	-210.21M	-213.13M	-198.5M	-182.23M	-170.4M	-156.63M	-148.28M	-137.03M	-128.89M	-117.99M
Comprehensive Income	n/a	-13K	18K	-21K	-92K	-72K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-688K	n/a	n/a	n/a	-443K	n/a	-2K	-24K	-70K	-103K	-205K	-205K	-169K	-8K	72K	-47K
Shareholders Equity	75.23M	79.58M	81.36M	94.33M	105.65M	116.71M	130.09M	142.86M	154.87M	167.07M	178.97M	191.22M	200.34M	128.7M	137.12M	141.69M	66.88M	72.33M	71.54M	72.67M	76.72M	90.68M	85.83M	98.89M	114.09M	124.61M	136.94M	144.66M	155.36M	92.09M	102.39M
Total Investments	53.28M	50.95M	47.94M	58.5M	66.54M	38.93M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.01M	26.05M	56.05M	72.59M	104.13M	120.67M	120.8M	76.38M	76.75M	71.65M